Dogwood Therapeutics, Inc.
DWTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001818844
No open-market purchases or sales by Dogwood Therapeutics, Inc. insiders were filed in the last 90 days; 15 institutions reported holding it in 13F filings for Q2 2026, worth $6.16M in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Dogwood Therapeutics, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 24
- +5 vs. Q1 2024
- Shares held
- 986.3K
- +310.5K (+46.0%) vs. Q1 2024
- Total value
- $212.0K
- −$112.0K (−34.6%) vs. Q1 2024
- New holders
- 7
- 3 more added
- Sold out
- 2
- 2 more reduced
1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DWTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 15 | $6.16M |
| Q1 2026 | 13 | $7.64M |
| Q4 2025 | 10 | $292.0K |
| Q3 2025 | 12 | $299.5K |
| Q2 2025 | 10 | $207.5K |
| Q1 2025 | 13 | $409.8K |
| Q4 2024 | 10 | $76.5K |
| Q3 2024 | 24 | $180.3K |
| Q2 2024 | 24 | $212.0K |
| Q1 2024 | 20 | $324.9K |
| Q4 2023 | 20 | $493.4K |
| Q3 2023 | 23 | $766.3K |
| Q2 2023 | 24 | $1.08M |
| Q1 2023 | 23 | $307.1K |
| Q4 2022 | 27 | $307.7K |
| Q3 2022 | 25 | $485.7K |
| Q2 2022 | 17 | $4.80M |
| Q1 2022 | 15 | $4.91M |
| Q4 2021 | 16 | $4.85M |
| Q3 2021 | 13 | $5.30M |
| Q2 2021 | 14 | $5.58M |
| Q1 2021 | 14 | $5.06M |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Dogwood Therapeutics, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 208,883 | $44.9K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 174,469 | $37.5K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 151,779 | $32.6K | 0.00% | +151,779 | New |
| Susquehanna International Group, LLP | 65,991 | $14.2K | 0.00% | +42,628+182.5% | Added |
| McCollum Christoferson Group LLC | 57,000 | $12.3K | 0.00% | +15,000+35.7% | Added |
| HRT Financial LP | 57,544 | $12.0K | 0.00% | +57,544 | New |
| State Street Corp | 52,828 | $11.4K | 0.00% | 00.0% | Unchanged |
| XTX Topco Ltd | 42,650 | $9.17K | 0.00% | +42,650 | New |
| Raymond James & Associates | 30,000 | $6.45K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 24,035 | $5.17K | 0.00% | 00.0% | Unchanged |
| Regions Financial Corp | 20,072 | $4.32K | 0.00% | 00.0% | Unchanged |
| Northwestern Mutual Wealth Management Co | 19,062 | $4.10K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 15,000 | $3.23K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 11,850 | $3.00K | 0.00% | +11,850 | New |
| Cetera Investment Advisers | 11,901 | $2.56K | 0.00% | −200−1.7% | Reduced |
| Wiley Bros.-Aintree Capital, LLC | 11,000 | $2.37K | 0.00% | 00.0% | Unchanged |
| One + One Wealth Management, LLC | 10,000 | $2.15K | 0.00% | +10,000 | New |
| William Howard & Co Financial Advisors Inc | 10,072 | $2.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 6,876 | $1.48K | 0.00% | +65+1.0% | Added |
| Activest Wealth Management | 3,000 | $645 | 0.00% | +3,000 | New |
| Group One Trading, L.P. | 1,297 | $279 | 0.00% | −6,814−84.0% | Reduced |
| BlackRock Inc. | 755 | $162 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 139 | $30 | 0.00% | +139 | New |
| Royal Bank of Canada | 56 | $0 | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −16,998−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −133−100.0% | Sold out |
| Cutler Group LP | – | – | – | – | Not filed |